These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 7757870)
21. ASHP national survey of hospital-based pharmaceutical services--1992. Crawford SY; Myers CE Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870 [TBL] [Abstract][Full Text] [Related]
22. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs). Krska J Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956 [TBL] [Abstract][Full Text] [Related]
23. The role of the pharmacy department in the prevention of adverse drug events: a survey of current practices. Lin B; Anderson LR Pharm Pract Manag Q; 1997 Apr; 17(1):10-6. PubMed ID: 10166240 [TBL] [Abstract][Full Text] [Related]
24. ASHP guidelines on preventing medication errors with chemotherapy and biotherapy. Goldspiel B; Hoffman JM; Griffith NL; Goodin S; DeChristoforo R; Montello CM; Chase JL; Bartel S; Patel JT Am J Health Syst Pharm; 2015 Apr; 72(8):e6-e35. PubMed ID: 25825193 [No Abstract] [Full Text] [Related]
25. Professional Policies Approved by the 2016 ASHP Virtual House of Delegates. Am J Health Syst Pharm; 2017 Feb; 74(4):e95. PubMed ID: 28179251 [No Abstract] [Full Text] [Related]
26. Reassessing the membership structure of ASHP. Williams RB Am J Hosp Pharm; 1992 May; 49(5):1186-90. PubMed ID: 1595751 [TBL] [Abstract][Full Text] [Related]
27. ASHP Multihospital Health-System Pharmacy Executives Leadership Symposium: Forecasting the future of pharmacy: A five-year plan October 19, 2014. Am J Health Syst Pharm; 2016 Feb; 73(4):247-53. PubMed ID: 26843503 [No Abstract] [Full Text] [Related]
28. Creating innovative leadership roles to improve pharmacy practice. Hertig JB; Radman D; Sisodiya D; Dabestani A Am J Health Syst Pharm; 2013 Feb; 70(4):306-7, 309. PubMed ID: 23370137 [No Abstract] [Full Text] [Related]
29. Improving the reporting of adverse drug reactions in the hospital setting. Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792 [TBL] [Abstract][Full Text] [Related]
30. ASHP statement on criteria for an intermediate category of drug products. American Society of Health-System Pharmacists Am J Health Syst Pharm; 2009 Mar; 66(5):502-5. PubMed ID: 19241626 [No Abstract] [Full Text] [Related]
31. Leadership obligations and the ASHP national surveys. Weber RJ Am J Health Syst Pharm; 2015 Jul; 72(13):1095. PubMed ID: 26092959 [No Abstract] [Full Text] [Related]
32. ASHP national survey of hospital-based pharmaceutical services--1994. Santell JP Am J Health Syst Pharm; 1995 Jun; 52(11):1179-98. PubMed ID: 7656108 [TBL] [Abstract][Full Text] [Related]
33. ASHP guidelines on clinical drug research. American Society of Health-System Pharmacists. Am J Health Syst Pharm; 1998 Feb; 55(4):369-75. PubMed ID: 9504197 [No Abstract] [Full Text] [Related]
34. Professional Policies Approved by the 2017 ASHP March Virtual House of Delegates. Am J Health Syst Pharm; 2017 Jun; 74(12):e338. PubMed ID: 28596232 [No Abstract] [Full Text] [Related]
35. International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Food and Drug Administration's Misguided Veterinary Guidance. Miller DG Int J Pharm Compd; 2015; 19(6):449-50. PubMed ID: 26891558 [No Abstract] [Full Text] [Related]
36. ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education--2009. Pedersen CA; Schneider PJ; Scheckelhoff DJ Am J Health Syst Pharm; 2010 Apr; 67(7):542-58. PubMed ID: 20237382 [TBL] [Abstract][Full Text] [Related]
37. ASHP guidelines on home infusion pharmacy services. Petroff BJ; Filibeck D; Nowobilski-Vasilios A; Olsen RS; Rollins CJ; Johnson C Am J Health Syst Pharm; 2014 Feb; 71(4):325-41. PubMed ID: 24481158 [No Abstract] [Full Text] [Related]
38. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2012. Pedersen CA; Schneider PJ; Scheckelhoff DJ Am J Health Syst Pharm; 2013 May; 70(9):787-803. PubMed ID: 23592362 [TBL] [Abstract][Full Text] [Related]
39. ASHP statement on the use of medications for unlabeled uses. Am J Hosp Pharm; 1992 Aug; 49(8):2006-8. PubMed ID: 1442846 [No Abstract] [Full Text] [Related]
40. Using integrated learning modules to increase involvement in ASHP student society. Obua U; Sabackic M; Goldman-Levine J Am J Health Syst Pharm; 2012 Feb; 69(4):277. PubMed ID: 22302251 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]